The videos below offer a core and relatively comprehensive basic knowledge of cannabis medicine and its components, including cannabinoids (such as THC, THC-A, and CBD) and terpenes (like myrcene and limonene).
This is a valuable body of information for any patient, caregiver, physician, or legalization advocate who embraces medical cannabis and the science of the human endocannabinoid system, including the entourage effect and endocannabinoid deficiency.
Those who believe in safe access to laboratory-tested, high-quality cannabis medicine for all Americans are encouraged to gain as much knowledge as possible regarding the plant and its efficacy for human disease. This includes not only conditions such as cancer, multiple sclerosis, and epilepsy, but also psychological conditions like depression, anxiety, and PTSD.
Dr. Sunil Aggarwal (MD, Ph.D.)
Dr. Sunil Aggarwal is a Seattle-based scientist, physician, and cannabinoid integrative medicine subspecialist who focuses on hospice and palliative care. He is a self-described “medical geographer” and a powerful voice in the movement to legalize and legitimize medical cannabis.
Aggarwal, a tireless patient advocate, has dedicated his professional life to researching medical cannabis, especially in terminal and aging patients. His lectures and writing offer some of the most lucid, intelligent, and compassionate arguments available for the use of cannabis as medicine.
Aggarwal is one of the few medical professionals to speak frankly about the corruption and propaganda that led to the federal prohibition of cannabis in 1937 and that has prevented its widespread use in both mainstream and alternative medical circles for nearly 80 years.
“To understand cannabis scientifically, a holistic point of view is essential as the human-plant relationship itself must be acknowledged.” — Dr. Sunil Aggarwal
- Explaining the AMA’s History on Cannabis (2:16; 2010)
- Let Them Talk (28:14; 2012)
- About the Expert: Sunil Aggarwal (1:48; 2013)
- Does Marijuana Cure Glaucoma? (3:10; 2013)
- 2014 Interview (1:00:00; 2014)
Mara Gordon (Aunt Zelda’s)
Mara Gordon is a specialist in the development of cannabis extract treatment protocols for seriously ill patients. She lives and works in California. A prolific and gifted speaker, Gordon is co-founder of Aunt Zelda’s and Zelda Therapeutics.
The only thing greater than Gordon’s presentation skills is her knowledge of the cannabis plant and its nuanced interaction with the body’s endocannabinoid system. Her science-based, moderate approach is one of the most well-spoken and relatable messages within the cannabis legalization movement; her presentations are among the most educational available.
“The goal of the endocannabinoid system is homeostasis. It is to create a sort of balance, or equilibrium, within the body. The theories are, of course, that when you have imbalance, or lack of homeostasis, in the body, that is when disease can occur.” — Mara Gordon
- Higher Learning (20:00; 2015)
- United in Compassion (Australia) (1:09:00; 2015)
- Clinical Application of Cannabinoids & Terpenes for Chronic Illnesses (Prague) (1:05:00)
- Clinical Applications of Cannabinoids & Terpenes for Chronic Illnesses (Costa Rica) (41:00; 2015)
Dr. Amanda Reiman (Drug Policy Alliance)
Dr. Amanda Reiman, manager of Marijuana Law and Policy for the Drug Policy Alliance, brings extensive experience in researching medical cannabis, dispensaries, and cannabis as a treatment agent for addiction. This Oakland, California-based cannabis legalization advocate is another top-shelf presenter with a keenly deep knowledge of her subject matter.
Dr. Reiman, a Chicago native, is currently a lecturer in the School of Social Welfare at the University of California at Berkeley. She teaches Drug and Alcohol Policy, Substance Abuse Treatment, and Sexuality and Social Work.
She earned her Ph.D. in Social Welfare in 2006 at the University of California, Berkeley. Her dissertation, Cannabis Care, was the first study to report on how medical cannabis dispensaries operate as health service providers.
“It’s like we’re dancing all around the [cannabis] research question. We’re getting at it from every possible angle, given the restriction. Everything but that golden ticket of [the] feds [funding] clinical research through universities with actual marijuana with people. We have not gotten there yet.” — Dr. Amanda Reiman
- Patient as Informed Consumer (12:59; 2012)
- The Science and Politics of Medical Marijuana (42:54; 2011)
- Addiction Conference lecture (21:51; 2013)
- Topics in Harm Reduction Interview (43:37; 2013)
All text and photos, unless otherwise noted, Copyright © 2003-2017 Gooey Rabinski. All Rights Reserved.
Gooey Rabinski is a technical writer, photographer, and compliance documentation specialist for cannabis businesses who has contributed feature articles to magazines and media outlets such as High Times, CannaBiz Journal, MERRY JANE, Emerald Magazine, Grow Magazine, Herb.co, The Kind, Skunk, Cannabis Culture, Whaxy, Heads, Weed World, Green Flower Media, Cannabis Health Journal, Green Thumb, and Treating Yourself.
He is the author of Understanding Medical Marijuana, available on Amazon Kindle.